Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Desmoid Tumors 1

Interventions

entrectinib 2 venetoclax 1 trametinib 1 tazemetostat 1 sodium thiosulfate 1 selpercatinib 1 ripretinib 1 repotrectinib 1 pirtobrutinib 1 pembrolizumab 1 nirogacestat 1 larotrectinib 1 dabrafenib 1 avapritinib 1 atezolizumab 1 Taxes 1 Specimen Handling 1 Rituximab 1 Restraint, Physical 1 Paclitaxel 1 Immunoglobulin G 1 Disulfides 1 Carboplatin 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × nirogacestat × Sarcoma × Clear all

NCT03785964 2025-01-31

DeFi

SpringWorks Therapeutics, Inc.

Phase 3 Completed

142 enrolled 21 charts 1 FDA

Desmoid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡